Poly Medicure Limited · NSE:POLYMED

Poly Medicure Limited financial statements

Poly Medicure Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue18.8B16.7B13.8B11.2B9.23B7.86B6.87B6.11B5.20B4.55B
Cost of revenue11.1B5.59B4.87B4.09B3.51B2.64B2.19B2.11B1.67B1.57B
Gross profit7.61B11.1B8.89B7.06B5.72B5.23B4.68B4.00B3.54B2.98B
Research and development298.8M245.7M194.4M178.0M187.7M131.4M119.4M101.5M100.5M90.3M
Selling, general and administrative1.08B3.05B2.48B2.05B1.66B1.44B1.40B1.19B1.01B887.4M
Operating income3.27B7.76B6.18B4.81B3.87B3.65B3.13B2.68B2.40B1.96B
Depreciation and amortization1.16B831.8M639.3M571.7M539.5M475.2M405.3M372.9M292.4M237.3M
EBITDA4.42B8.59B6.82B5.38B4.40B4.12B3.53B3.05B2.69B2.20B
Interest expense182.9M140.0M130.5M81.9M57.4M90.8M120.1M136.7M109.7M85.5M
Income before tax4.27B4.53B3.44B2.37B1.95B1.80B1.26B1.00B967.5M751.9M
Income tax1.07B1.14B860.1M582.1M487.4M441.8M298.5M346.8M261.6M200.6M
Net income3.22B3.39B2.58B1.79B1.47B1.36B958.8M654.0M705.9M551.3M
Earnings per share, basic31.7534.1126.9018.6715.2715.2410.867.418.006.25

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents878.7M1.51B120.5M70.6M77.6M49.5M48.6M43.2M37.0M226.2M
Short-term investments7.39B10.6B2.74B2.94B3.44B3.69B361.1M503.2M271.6M238.3M
Receivables5.32B3.50B2.70B2.43B2.07B1.56B1.36B1.43B1.39B-20.2M
Inventory4.34B2.86B2.21B2.09B1.68B1.26B1.12B837.9M729.9M639.3M
Current assets19.4B19.2B8.42B8.07B7.83B7.06B3.18B3.02B2.55B2.05B
Property, plant and equipment11.3B8.89B6.62B4.77B3.91B3.32B2.70B2.58B2.06B
Goodwill2.74B285.8M285.8M285.8M285.8M285.8M285.8M285.8M
Total assets39.2B31.9B18.6B15.8B13.8B12.2B7.67B6.54B5.65B4.55B
Accounts payable1.23B864.2M956.0M923.1M890.4M645.2M663.6M555.4M436.2M418.6M
Current liabilities5.76B3.70B3.51B2.93B2.27B1.71B1.97B1.54B1.23B1.19B
Long-term debt520.9M010.9M175.0M381.3M632.8M1.11B911.2M782.9M463.1M
Total debt3.54B1.80B1.74B1.49B1.27B1.37B2.07B1.61B1.33B799.9M
Total liabilities7.69B4.27B3.89B3.36B2.89B2.58B3.33B2.73B2.27B1.90B
Shareholders' equity31.1B27.7B14.7B12.4B10.9B9.66B4.35B3.81B3.38B2.64B
Shares outstanding101.5M99.2M96.0M96.0M96.0M89.2M88.3M88.2M88.2M88.2M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations2.48B2.40B2.66B1.91B1.23B1.19B1.31B1.07B749.3M561.2M
Capital spending-3.08B-3.31B-2.77B-2.39B-1.56B-951.3M-1.06B-780.0M-824.6M-586.1M
Free cash flow-601.7M-906.1M-109.3M-484.5M-321.1M236.0M244.8M291.3M-75.3M-24.9M
Cash from investing-2.43B-11.9B-2.41B-1.79B-853.3M-4.36B-1.07B-1.02B-880.0M-618.0M
Cash from financing361.4M9.51B-201.5M-125.1M-353.4M3.17B-205.1M-45.9M157.1M-2.89M
Dividends paid-354.3M-303.4M-287.4M-239.7M-239.2M-239.2M-424.7M-211.9M-53.1M-132.7M
Share buybacks10.0B2.64M3.51M989.0K4.00B503.0K-282.4M
Change in cash787.1M-33.5M49.9M-6.95M28.0M972.0K5.40M6.17M26.4M-59.7M